diphenylamine has been researched along with interleukin-8 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagrodia, S; Burns-Naas, LA; Evering, W; Hu, W; John-Baptiste, A; Marroquin, LD; Palmer, CL; Smeal, T; Torti, VR; Troche, G; Wojciechowicz, D; Yamazaki, S | 1 |
1 other study(ies) available for diphenylamine and interleukin-8
Article | Year |
---|---|
Epithelial tissue hyperplasia induced by the RAF inhibitor PF-04880594 is attenuated by a clinically well-tolerated dose of the MEK inhibitor PD-0325901.
Topics: Animals; Benzamides; Diphenylamine; Dogs; Dose-Response Relationship, Drug; Epidermis; Epithelium; Extracellular Signal-Regulated MAP Kinases; HL-60 Cells; Humans; Hyperplasia; Interleukin-8; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Phosphorylation; Protein Kinase Inhibitors; Protein Multimerization; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyrazoles; Pyrimidines | 2012 |